Expertise in
4
conditions

Dr. Jeffrey Kaine

Rheumatology
Sarasota Therapy Center
1945 Versailles St Fl 2, 
Sarasota, FL 
Expertise in
4
conditions
Sarasota Therapy Center
1945 Versailles St Fl 2, 
Sarasota, FL 

Overview

Jeffrey Kaine is a Rheumatologist practicing medicine in Sarasota, Florida.

Dr. Kaine is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Axial Spondyloarthritis (AxSpA), and Ankylosing Spondylitis.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 8 clinical trials.

Specialties

Rheumatology

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Sarasota Therapy Center
1945 Versailles St Fl 2, Sarasota, FL 34239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study
A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study
Enrollment Status: Terminated
Publish Date: October 09, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

12 Total Publications

Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States.
Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States.
Journal: ACR open rheumatology
Published: August 26, 2022
Similar Doctors
Expertise in
17
conditions
Dr. Yoel Drucker
Rheumatology
Expertise in
17
conditions
Dr. Yoel Drucker
Rheumatology
Referral required

Sarasota Therapy Center

1945 Versailles St Fl 2, 
Sarasota, FL 
 (1.0 miles away)
941-365-0770
Languages Spoken:
English
See accepted insurances

Yoel Drucker is a Rheumatologist practicing medicine in Sarasota, Florida. Dr. Drucker is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Psoriatic Arthritis.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Millennium Physician Group LLC

8383 S Tamiami Trl Unit 115, 
Sarasota, FL 
 (5.9 miles away)
941-497-4069
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sampath Manickam is a Rheumatologist practicing medicine in Sarasota, Florida. Dr. Manickam is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), IgG4-Related Disease, Light Chain Deposition Disease (LCDD), and MAGIC Syndrome.

Expertise in
29
conditions
Dr. Leslie Tar
Rheumatology
Expertise in
29
conditions
Dr. Leslie Tar
Rheumatology
Referral may be required

Allergy & Arthritis Treatment Centers LLC

22226 Westchester Blvd, 
Port Charlotte, FL 
 (35.8 miles away)
914-244-8612
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Tar is a Rheumatologist practicing medicine in Port Charlotte, Florida. Dr. Tar is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Fibromyalgia, Hives, and Common Variable Immune Deficiency.

Frequently Asked Questions about Dr. Jeffrey Kaine

How do I make an appointment with Dr. Jeffrey Kaine?

You can book an appointment with Dr. Jeffrey Kaine by calling their office at 941-365-0770. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey Kaine a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey Kaine is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey Kaine specialize in?

While Dr. Jeffrey Kaine is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Arthritis, and Axial Spondyloarthritis (AxSpA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Jeffrey Kaine participate in research or clinical trials?

Yes. Dr. Jeffrey Kaine has published 12 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Jeffrey Kaine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey Kaine accept my insurance?

Dr. Jeffrey Kaine accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 941-365-0770 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kaine's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile